Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1652, 2008-01, pp. : 23-23
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sygnis receives orphan drug designation for AX 200.
Inpharma, Vol. 1, Iss. 1665, 2008-01 ,pp. :
Access to resources
Recommend
Sapacitabine receives orphan drug designation in EU.
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :
US orphan drug designation granted for MGCD0103
Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. :
Orphan drug designation in the EU
Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. :
US FDA grants orphan drug designation for imisopasem manganese
Inpharma, Vol. 1, Iss. 1629, 2008-01 ,pp. :